title: [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
authors.forename: J
authors.initials: J
authors.lastname: Sznajd
authors.forename: M
authors.initials: M
authors.lastname: Malczewska-Malec
authors.forename: B
authors.initials: B
authors.lastname: Idzior-Waluś
authors.forename: J
authors.initials: J
authors.lastname: Iwanejko
authors.forename: G
authors.initials: G
authors.lastname: Nowacki
mesh_terms: D001053:Apolipoproteins / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D015248:Gemfibrozil; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000188:drug therapy*; D010421:Pentanoic Acids / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014631:Valerates / Q000627:therapeutic use*
chemical_list: D001053:Apolipoproteins; D010421:Pentanoic Acids; D014280:Triglycerides; D014631:Valerates; D002784:Cholesterol; D015248:Gemfibrozil
vernacular_title: Ocena skuteczności Gemfibrozilu w pierwotnych dyslipoproteinemiach. Czećć II: Zalezność wyników leczenia od postaci dyslipoproteinemii.